申请人:Joint Stock Company "Biocad"
公开号:EP3666770A1
公开(公告)日:2020-06-17
The present invention relates to novel compounds of formula (I):
or a pharmaceutically acceptable salt or stereoisomer thereof, which exhibit the properties of a CDK 8/19 inhibitor. The invention also relates to a pharmaceutical composition containing said compounds and to the use thereof as pharmaceutical drugs for treating diseases or disorders.
本发明涉及式 (I) 的新型化合物:
或其药学上可接受的盐或立体异构体,它们具有 CDK 8/19 抑制剂的特性。本发明还涉及含有上述化合物的药物组合物,以及将其用作治疗疾病或失调的药物。